Tag "Blueprint Medicines"
Sanofi to buy US drugmaker for over $9 billion
French pharmaceutical company Sanofi is acquiring biopharmaceutical company Blueprint Medicines, a U.S. developer of drugs for the treatment of rare autoimmune diseases, for more than $9 billion, according to Sanofi’s...
Read more